Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › SC › GREENVILLE › PRISMA HEALTH-UPSTATE

PRISMA HEALTH-UPSTATE

NPI: 1124574223 · GREENVILLE, SC 29615 · General Acute Care Hospital · NPI assigned 08/29/2016

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official MILLER, POLLY controls 20+ related entities in our dataset. Read more

$967K
Total Medicaid Paid
46,555
Total Claims
39,962
Beneficiaries
85
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialMILLER, POLLY (VP PAYOR STRATEGIES & ALIGNMENT)
NPI Enumeration Date08/29/2016

Related Entities

Other providers sharing the same authorized official: MILLER, POLLY

ProviderCityStateTotal Paid
PRISMA HEALTH-MIDLANDS COLUMBIA SC $74.58M
PRISMA HEALTH-MIDLANDS COLUMBIA SC $68.26M
PRISMA HEALTH-UPSTATE GREENVILLE SC $25.04M
PRISMA HEALTH-UPSTATE GREENVILLE SC $21.98M
PRISMA HEALTH-UPSTATE GREENVILLE SC $19.69M
PRISMA HEALTH-UPSTATE SENECA SC $15.64M
PRISMA HEALTH-MIDLANDS COLUMBIA SC $11.77M
PRISMA HEALTH-UPSTATE GREENVILLE SC $10.74M
GREENVILLE HEALTH CORPORATION GREENVILLE SC $8.90M
PRISMA HEALTH-UPSTATE GREENVILLE SC $8.32M
PRISMA HEALTH-UPSTATE GREENVILLE SC $7.45M
PRISMA HEALTH UNIVERSITY MEDICAL GROUP GREENVILLE SC $7.44M
PRISMA HEALTH-MIDLANDS COULMBIA SC $7.43M
PRISMA HEALTH-MIDLANDS COLUMBIA SC $6.88M
PRISMA HEALTH TUOMEY SUMTER SC $6.84M
PRISMA HEALTH-MIDLANDS COLUMBIA SC $6.77M
PRISMA HEALTH-UPSTATE GREENVILLE SC $6.37M
PRISMA HEALTH-UPSTATE GREENVILLE SC $5.00M
PRISMA HEALTH-UPSTATE GREENVILLE SC $4.65M
PRISMA HEALTH-MIDLANDS COLUMBIA SC $4.63M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 3,092 $41K
2019 4,337 $47K
2020 5,567 $82K
2021 8,979 $142K
2022 8,904 $248K
2023 7,963 $166K
2024 7,713 $239K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 137 137 $239K
36415 Collection of venous blood by venipuncture 2,879 2,386 $215K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2,467 2,262 $145K
81025 406 392 $50K
64493 398 386 $48K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 359 349 $43K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study 166 162 $35K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 539 480 $24K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 418 354 $24K
80053 Comprehensive metabolic panel 1,083 1,007 $18K
87070 996 944 $17K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 542 511 $15K
96376 248 191 $12K
87077 496 470 $11K
J3490 Unclassified drugs 3,548 2,254 $11K
87086 Culture, bacterial; quantitative colony count, urine 1,024 972 $9K
59025 Fetal non-stress test 617 540 $8K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 410 400 $4K
86850 193 181 $4K
81001 498 474 $3K
99215 Prolong outpt/office vis 46 39 $3K
82570 471 417 $3K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 13 13 $3K
78815 Positron emission tomography (PET) for limited area imaging 98 98 $3K
80048 Basic metabolic panel (calcium, ionized) 544 466 $2K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 34 34 $2K
85610 72 64 $2K
88305 Level IV - Surgical pathology, gross and microscopic examination 54 51 $2K
82247 91 67 $2K
83993 43 42 $2K
85027 1,431 1,350 $1K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 13 13 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg 882 577 $1K
G0378 Hospital observation service, per hour 810 686 $914.86
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 284 265 $833.79
85025 Blood count; complete (CBC), automated, and automated differential WBC count 256 240 $785.77
87081 306 302 $665.16
96361 Intravenous infusion, hydration; each additional hour 154 104 $611.95
J1100 Injection, dexamethasone sodium phosphate, 1 mg 2,580 2,286 $445.36
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 476 446 $210.04
J0690 Injection, cefazolin sodium, 500 mg 2,834 1,792 $82.48
J2795 Injection, ropivacaine hydrochloride, 1 mg 1,019 978 $53.72
J1030 Injection, methylprednisolone acetate, 40 mg 29 27 $48.70
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 441 289 $24.52
J2405 Injection, ondansetron hydrochloride, per 1 mg 2,509 2,155 $21.53
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 54 50 $15.93
84156 131 109 $4.87
J7120 Ringers lactate infusion, up to 1000 cc 2,869 2,646 $0.93
J2250 Injection, midazolam hydrochloride, per 1 mg 2,084 1,942 $0.42
J1170 Injection, hydromorphone, up to 4 mg 1,953 1,526 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 436 419 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 626 596 $0.00
87205 400 386 $0.00
85018 88 84 $0.00
97162 159 153 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 324 276 $0.00
86901 189 178 $0.00
88307 67 64 $0.00
64494 116 112 $0.00
51798 26 24 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 71 68 $0.00
96375 Therapeutic injection; each additional sequential IV push 134 102 $0.00
93320 140 136 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 27 27 $0.00
64483 13 12 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 21 16 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 145 141 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 1,707 1,555 $0.00
97530 Therapeutic activities, direct patient contact, each 15 minutes 170 132 $0.00
J0735 Injection, clonidine hydrochloride, 1 mg 119 115 $0.00
J3370 Injection, vancomycin hcl, 500 mg 105 102 $0.00
86900 189 178 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 86 34 $0.00
87186 364 343 $0.00
C1776 Joint device (implantable) 154 150 $0.00
85014 83 81 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 87 85 $0.00
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 19 19 $0.00
J1644 Injection, heparin sodium, per 1000 units 63 55 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 59 58 $0.00
J1171 Injection, hydromorphone, 0.1 mg 42 39 $0.00
J2270 Injection, morphine sulfate, up to 10 mg 15 14 $0.00
82248 48 37 $0.00
93325 141 137 $0.00
J7030 Infusion, normal saline solution , 1000 cc 117 108 $0.00